Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin

SIMPLE SUMMARY: The treatment options for advanced well differentiated liposarcoma (WDLPS) and dedifferentiated liposarcoma (DDLPS) are scant, especially after the failure of first-line, anthracycline-based treatment, when trabectedin is one of the most active agents currently approved. Thus, the id...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabbroni, Chiara, Fucà, Giovanni, Ligorio, Francesca, Fumagalli, Elena, Barisella, Marta, Collini, Paola, Morosi, Carlo, Gronchi, Alessandro, Dei Tos, Angelo Paolo, Casali, Paolo Giovanni, Sanfilippo, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005098/
https://www.ncbi.nlm.nih.gov/pubmed/33810165
http://dx.doi.org/10.3390/cancers13061453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005098/
https://www.ncbi.nlm.nih.gov/pubmed/33810165
http://dx.doi.org/10.3390/cancers13061453

Ejemplares similares